Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation

J Biol Chem. 2012 Feb 17;287(8):5600-14. doi: 10.1074/jbc.M111.289843. Epub 2011 Dec 20.

Abstract

Pre-B-cell leukemia homeobox interacting protein 1 or human PBX1 interacting protein (PBXIP1/HPIP) is a co-repressor of pre-B-cell leukemia homeobox 1 (PBX1) and is also known to regulate estrogen receptor functions by associating with the microtubule network. Despite its initial discovery in the context of hematopoietic cells, little is yet known about the role of HPIP in hematopoiesis. Here, we show that lentivirus-mediated overexpression of HPIP in human CD34(+) cells enhances hematopoietic colony formation in vitro, whereas HPIP knockdown leads to a reduction in the number of such colonies. Interestingly, erythroid colony number was significantly higher in HPIP-overexpressing cells. In addition, forced expression of HPIP in K562 cells, a multipotent erythro-megakaryoblastic leukemia cell line, led to an induction of erythroid differentiation. HPIP overexpression in both CD34(+) and K562 cells was associated with increased activation of the PI3K/AKT pathway, and corresponding treatment with a PI3K-specific inhibitor, LY-294002, caused a reduction in clonogenic progenitor number in HPIP-expressing CD34(+) cells and decreased K562 cell differentiation. Combined, these findings point to an important role of the PI3K/AKT pathway in mediating HPIP-induced effects on the growth and differentiation of hematopoietic cells. Interestingly, HPIP gene expression was found to be induced in K562 cells in response to erythroid differentiation signals such as DMSO and erythropoietin. The erythroid lineage-specific transcription factor GATA1 binds to the HPIP promoter and activates HPIP gene transcription in a CCCTC-binding factor (CTCF)-dependent manner. Co-immunoprecipitation and co-localization experiments revealed the association of CTCF with GATA1 indicating the recruitment of CTCF/GATA1 transcription factor complex onto the HPIP promoter. Together, this study provides evidence that HPIP is a target of GATA1 and CTCF in erythroid cells and plays an important role in erythroid differentiation by modulating the PI3K/AKT pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34 / metabolism
  • CCAAT-Enhancer-Binding Protein-alpha / metabolism
  • CCCTC-Binding Factor
  • Cell Differentiation* / drug effects
  • Chromatin / drug effects
  • Chromatin / genetics
  • Chromatin / metabolism
  • Co-Repressor Proteins
  • Dimethyl Sulfoxide / pharmacology
  • Erythroid Cells / cytology*
  • Erythroid Cells / drug effects
  • Erythroid Cells / metabolism*
  • Erythropoietin / pharmacology
  • GATA1 Transcription Factor / metabolism
  • Gene Expression Regulation / drug effects
  • Gene Knockdown Techniques
  • HL-60 Cells
  • Hematopoiesis / drug effects
  • Humans
  • K562 Cells
  • Myeloid Cells / cytology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Repressor Proteins / metabolism
  • Signal Transduction / drug effects
  • Transcription Factors / deficiency
  • Transcription Factors / genetics
  • Transcription Factors / metabolism*
  • Transcription, Genetic / drug effects

Substances

  • Antigens, CD34
  • CCAAT-Enhancer-Binding Protein-alpha
  • CCCTC-Binding Factor
  • CTCF protein, human
  • Chromatin
  • Co-Repressor Proteins
  • GATA1 Transcription Factor
  • GATA1 protein, human
  • PBXIP1 protein, human
  • Repressor Proteins
  • Transcription Factors
  • Erythropoietin
  • Proto-Oncogene Proteins c-akt
  • Dimethyl Sulfoxide